China establishes COVID-19 convalescent-plasma supply network
BEIJING — China has established a national supply network for COVID-19 convalescent plasma, with a reserve bank in Wuhan, in Central Hubei province, and similar stocks located in provinces across the country, a health official said on June 10.
Guo Yanhong, an official with the National Health Commission, said at a press conference that the plasma, collected from COVID-19 patients who were recovering from the disease, had proven effective in treating severe COVID-19 patients.
So far, the country has collected a total of 1.47 million ml of plasma from more than 4,700 donations, around 60 percent of which were made in Hubei, Guo said.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


